NeuralStem Inc. Reports First Quarter Financial Results and Provides Business and Clinical Update
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ROCKVILLE, Md., May 10, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2013 and provided a business and clinical update.
"The Company continues to progress all of its clinical trial programs, in the U.S. and abroad, as we move into 2013.
Help employers find you! Check out all the jobs and post your resume.
ROCKVILLE, Md., May 10, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2013 and provided a business and clinical update.
"The Company continues to progress all of its clinical trial programs, in the U.S. and abroad, as we move into 2013.
Help employers find you! Check out all the jobs and post your resume.